Istaroxime, a first in class new chemical entity exhibiting...

Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na–K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?

Hashim Khan, Marco Metra, John E. A. Blair, Mark Vogel, Matthew E. Harinstein, Gerasimos S. Filippatos, Hani N. Sabbah, Herve Porchet, Giovanni Valentini, Mihai Gheorghiade
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Pages:
11
DOI:
10.1007/s10741-009-9136-z
Date:
December, 2009
File:
PDF, 554 KB
english, 2009
Conversion to is in progress
Conversion to is failed